Aptamers Market is expected to reach US$4,333.0 Million by 2019;Modification of Chemical Structure Prove to be Promising for the Growth of this Market

Aptamers have a great potential and thus, many private organizations in the U.S. and the U.K. are engaged in funding and further development of the aptamer field. This is expected to drive the growth of the market. Aptamers are increasingly being perceived as an attractive solution for research applications owing to the unique production methodology. The production of aptamers do not require animals, thus avoiding animal abuse and death. This eliminates the need for companies to send animal protocol the Institutional Animal Care and Use Committee (IACUC) for aptamer development. Another factor driving the market is the high specificity and selectivity of aptamers, owing to which, the volume required for analysis can be reduced. This helps in increasing the speed of the research analysis, driving their demand. “There are no formal regulatory guidelines aptamers, which specifically addresses the quality expectations of these drugs.,” says a TMR analyst. The regulatory expectation of aptamer-based drugs is still evolving and the development of regulatory guidelines, which would satisfactorily address quality and safety requirements is challenging. However, aptamer modifications can be made to increase half-life or to enhance therapeutic abilities. In addition to this, chemical structure modification of aptamer can also prove to be beneficial.

Download PDF Brochure to know more about Aptamers - http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1335

The global aptamers market was valued at USD 93.0 million in 2012. It is estimated to reach USD 4,333.0 million by 2019 at a CAGR of 73.1% from 2013 to 2019.

North America accounted for the largest share i.e., over 45% of the global aptamers market in 2012. The market in North America has been boosted by the presence of a large number of key players and increasing research and development activities by domiciled players. Europe accounted for the second largest share of the total market in 2012. The aptamers market is majorly driven by increasing use of aptamer technologies by small-scale industries in Europe. Asia Pacific is expected to be the fastest growing region due to increasing initiatives undertaken by governments for the development of aptamer technology coupled with huge growth opportunities.

The global aptamers market is dominated by a few key players including Aptagen, Inc., Aptamer Group, Base Pair Biotechnologies, Inc., Somalogic, Inc. and NOXXON Pharma AG.

Read Report with Complete TOC - http://www.transparencymarketresearch.com/aptamers-market.html

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.